Skip to content

Is lowering of shear and friction forces (cost)effective for prevention of pressure ulcers?

Is lowering of shear and friction forces (cost)effective for prevention of pressure ulcers? A multicenter, prospective, controlled randomized clinical trial in Dutch nursing homes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23041
Enrollment
220
Registered
2014-03-28
Start date
2014-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure ulcer Prevention Shear and friction force Costs Decubituswond Preventie Schuif- en Wrijfkracht Kosten

Interventions

About half the population will receive a visco-elastic foam mattress and the other part the same type of mattress with the Bedcare Plus system on top of it.

Sponsors

SenseTextile BV Hertog Hendriklaan 6, 5062CJ te Oisterwijk
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both genders, age ≥ 60 years, mentally competent or incompetent 2. Life expectation >3 month 3. Chronic patient in nursing home 4. No pressure ulcer in last 3 months 5. Braden score 6-15 6. Patient or his legal representative has read and signed Informed consent form before treatment

Exclusion criteria

Exclusion criteria: 1. Patient is participating in another wound study. 2. Patient has any condition(s) like need of hospital care, cancer, sepsis that seriously compromises the patient’s ability to complete this study according to the judgment of the MD

Design outcomes

Primary

MeasureTime frame
Reduction of pressure ulcers on the new system with 30%.

Secondary

MeasureTime frame
Reduction of superficial pressure ulcers related to transfers, reduction of total cost prevention.

Contacts

Public ContactM.W.F. Leen, van

Organisatie: Avoord Zorg en Wonen. Afdeling: Medische zaken.

m.van.leen@avoord.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)